Applied Therapeutics (APLT) Insider Trading & Ownership $8.69 -0.32 (-3.55%) (As of 11/15/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Applied Therapeutics (NASDAQ:APLT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$65,400.00Number OfInsiders Selling(Last 12 Months)4Amount OfInsider Selling(Last 12 Months)$6.05 M Get APLT Insider Trade Alerts Want to know when executives and insiders are buying or selling Applied Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address APLT Insider Buying and Selling by Quarter Ad ReticulateThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t Applied Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/14/2024Shoshana ShendelmanCEOSell119,591$5.93$709,174.63 8/12/2024Shoshana ShendelmanCEOSell300,000$5.98$1,794,000.00 6/6/2024Leslie D FuntleyderCFOSell16,980$4.32$73,353.60 6/6/2024Riccardo PerfettiInsiderSell22,003$4.32$95,052.96 6/6/2024Shoshana ShendelmanCEOSell61,795$4.32$266,954.40 6/4/2024Real Estate Equitie AlexandriaMajor ShareholderSell150,000$4.21$631,500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/14/2024Leslie D FuntleyderCFOSell28,727$5.39$154,838.53 3/14/2024Riccardo PerfettiInsiderSell110,804$5.39$597,233.56 3/14/2024Shoshana ShendelmanCEOSell318,573$5.39$1,717,108.47 12/1/2023Stacy J KanterDirectorBuy30,000$2.18$65,400.00 11/30/2023Riccardo PerfettiInsiderSell1,583$1.97$3,118.51 11/30/2023Shoshana ShendelmanCEOSell3,968$1.97$7,816.96 (Data available from 1/1/2013 forward) APLT Insider Trading Activity - Frequently Asked Questions Who is on Applied Therapeutics's Insider Roster? The list of insiders at Applied Therapeutics includes Chids Mahadevan, Leslie D Funtleyder, Real Estate Equitie Alexandria, Riccardo Perfetti, Shoshana Shendelman, and Stacy J Kanter. Learn more on insiders at APLT. What percentage of Applied Therapeutics stock is owned by insiders? 8.60% of Applied Therapeutics stock is owned by insiders. Learn more on APLT's insider holdings. Which Applied Therapeutics insiders have been buying company stock? The following insider purchased APLT shares in the last 24 months: Stacy J Kanter ($65,400.00). How much insider buying is happening at Applied Therapeutics? Insiders have purchased a total of 30,000 APLT shares in the last 24 months for a total of $65,400.00 bought. Which Applied Therapeutics insiders have been selling company stock? The following insiders have sold APLT shares in the last 24 months: Leslie D Funtleyder ($228,192.13), Real Estate Equitie Alexandria ($1,245,884.56), Riccardo Perfetti ($730,429.66), and Shoshana Shendelman ($4,821,702.56). How much insider selling is happening at Applied Therapeutics? Insiders have sold a total of 1,541,319 Applied Therapeutics shares in the last 24 months for a total of $7,026,208.91 sold. Applied Therapeutics Key ExecutivesDr. Shoshana Shendelman Ph.D. (Age 45)Chair of the Board of Directors, Founder, President, CEO & Secretary Compensation: $946.08kMr. Les D. Funtleyder (Age 53)CFO, Principal Financial Officer & Independent Director Compensation: $48.75k1 recent tradesDr. Riccardo Perfetti M.D. (Age 63)Ph.D., Chief Medical Officer Compensation: $860.76kMr. Constantine Chinoporos (Age 58)COO & Chief Business Officer Ms. Catherine Thorpe (Age 60)Chief Accounting Officer Mr. Corwin Dale Hooks (Age 57)Chief Commercial Officer More Insider Trading Tools from MarketBeat Related Companies Prothena Insider Trades Avid Bioservices Insider Trades Dynavax Technologies Insider Trades G1 Therapeutics Insider Trades Rigel Pharmaceuticals Insider Trades Puma Biotechnology Insider Trades ADMA Biologics Insider Trades Organon & Co. Insider Trades TG Therapeutics Insider Trades ImmunityBio Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NASDAQ:APLT) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Applied Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Applied Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.